|
1
|
Lu X, Kang N, Ling X, Pan M, Du W and Gao
S: MiR-27a-3p promotes non-small cell lung cancer through
SLC7A11-mediated-ferroptosis. Front Oncol. 11:7593462021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu G, Hu C, Hui K, Zhang H, Chen T, Zhang
X and Jiang X: Exosomal miR-136-5p derived from anlotinib-resistant
NSCLC cells confers anlotinib resistance in non-small cell lung
cancer through targeting PPP2R2A. Int J Nanomedicine. 16:6329–6343.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang L, Hui K, Hu C, Wen Y, Yang S, Zhu
P, Wang L, Xia Y, Qiao Y, Sun W, et al: Autophagy inhibition
potentiates the anti-angiogenic property of multikinase inhibitor
anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung
cancer cells. J Exp Clin Cancer Res. 38:712019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Duff M, Gouju J, Jonchère B, Guillon J,
Toutain B, Boissard A, Henry C, Guette C, Lelièvre E and Coqueret
O: Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway
in response to chemotherapy. Cell Death Dis. 9:1992018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharpless NE and Sherr CJ: Forging a
signature of in vivo senescence. Nat Rev Cancer. 15:397–408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bolitho C, Moscova M, Baxter RC and Marsh
DJ: Amphiregulin increases migration and proliferation of
epithelial ovarian cancer cells by inducing its own expression via
PI3-kinase signaling. Mol Cell Endocrinol. 533:1113382021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Wang L, Zhang H, Lu J, Zhang Z, Wu
H and Liang Z: AREG mediates the epithelial-mesenchymal transition
in pancreatic cancer cells via the EGFR/ERK/NF-κB signalling
pathway. Oncol Rep. 43:1558–1568. 2020.PubMed/NCBI
|
|
8
|
Tu CY, Wang BW, Cheng FJ, Chen CH, Hsia
TC, Wei YL, Chen CY, Hsieh IS, Yeh YL, Wang LY, et al: Incense
burning smoke sensitizes lung cancer cells to EGFR TKI by inducing
AREG expression. Am J Cancer Res. 8:2575–2589. 2018.PubMed/NCBI
|
|
9
|
Fujino M, Tagami A, Ojima M, Mizuno S,
Abdellatif AM, Kuno A and Takahashi S: c-MAF deletion in adult
C57BL/6J mice induces cataract formation and abnormal
differentiation of lens fiber cells. Exp Anim. 69:242–249. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong E, Yik J, Amanatullah DF, Di Cesare
PE and Haudenschild DR: c-Maf transcription factor regulates
ADAMTS-12 expression in human chondrogenic cells. Cartilage.
4:177–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R, Zheng J, Zhang DS, Yang YH and
Zhao ZF: Wnt1-induced MAFK expression promotes osteosarcoma cell
proliferation. Genet Mol Res. 14:7315–7325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakurai T, Isogaya K, Sakai S, Morikawa M,
Morishita Y, Ehata S, Miyazono K and Koinuma D: RNA-binding motif
protein 47 inhibits Nrf2 activity to suppress tumor growth in lung
adenocarcinoma. Oncogene. 35:5000–5009. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malaquin N, Martinez A and Rodier F:
Keeping the senescence secretome under control: Molecular reins on
the senescence-associated secretory phenotype. Exp Gerontol.
82:39–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Massrieh W, Derjuga A, Doualla-Bell F, Ku
CY, Sanborn BM and Blank V: Regulation of the MAFF transcription
factor by proinflammatory cytokines in myometrial cells. Biol
Reprod. 74:699–705. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Almeida GM, Duarte TL, Farmer PB, Steward
WP and Jones GD: Multiple end-point analysis reveals cisplatin
damage tolerance to be a chemoresistance mechanism in a NSCLC
model: Implications for predictive testing. Int J Cancer.
122:1810–1819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mosieniak G, Sliwinska MA, Alster O,
Strzeszewska A, Sunderland P, Piechota M, Was H and Sikora E:
Polyploidy formation in doxorubicin-treated cancer cells can favor
escape from senescence. Neoplasia. 17:882–893. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang B, Shetti D, Fan C and Wei K:
miR-29b-3p promotes progression of MDA-MB-231 triple-negative
breast cancer cells through downregulating TRAF3. Biol Res.
52:382019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vétillard A, Jonchère B, Moreau M, Toutain
B, Henry C, Fontanel S, Bernard AC, Campone M, Guette C and
Coqueret O: Akt inhibition improves irinotecan treatment and
prevents cell emergence by switching the senescence response to
apoptosis. Oncotarget. 6:43342–43362. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jonchère B, Vétillard A, Toutain B, Lam D,
Bernard AC, Henry C, De Carné Trécesson S, Gamelin E, Juin P,
Guette C and Coqueret O: Irinotecan treatment and senescence
failure promote the emergence of more transformed and invasive
cells that depend on anti-apoptotic Mcl-1. Oncotarget. 6:409–426.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maarouf A, Boissard A, Henry C, Leman G,
Coqueret O, Guette C and Lelièvre E: Anterior gradient protein 2 is
a marker of tumor aggressiveness in breast cancer and favors
chemotherapy-induced senescence escape. Int J Oncol. 60:52022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Olszewska A, Borkowska A, Granica M,
Karolczak J, Zglinicki B, Kieda C and Was H: Escape from
cisplatin-induced senescence of hypoxic lung cancer cells can be
overcome by hydroxychloroquine. Front Oncol. 11:7383852022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dragoj M, Milosevic Z, Bankovic J, Tanic
N, Pesic M and Stankovic T: Targeting CXCR4 and FAK reverses
doxorubicin resistance and suppresses invasion in non-small cell
lung carcinoma. Cell Oncol (Dordr). 40:47–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmucker H, Blanding WM, Mook JM, Wade
JF, Park JP, Kwist K, Shah H and Booth BW: Amphiregulin regulates
proliferation and migration of HER2-positive breast cancer cells.
Cell Oncol (Dordr). 41:159–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bormann F, Stinzing S, Tierling S, Morkel
M, Markelova MR, Walter J, Weichert W, Roßner F, Kuhn N, Perner J,
et al: Epigenetic regulation of Amphiregulin and Epiregulin in
colorectal cancer. Int J Cancer. 144:569–581. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimada H, Abe S, Kohno T, Satohisa S,
Konno T, Takahashi S, Hatakeyama T, Arimoto C, Kakuki T, Kaneko Y,
et al: Loss of tricellular tight junction protein LSR promotes cell
invasion and migration via upregulation of TEAD1/AREG in human
endometrial cancer. Sci Rep. 7:370492017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee IN, Yang JT, Hsieh MJ, Huang C, Huang
HC, Ku YJ, Wu YP, Huang KC and Chen JC: Knockdown of amphiregulin
triggers doxorubicin-induced autophagic and apoptotic death by
regulating endoplasmic reticulum stress in glioblastoma cells. J
Mol Neurosci. 70:1461–1470. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen JC, Huang C, Lee IN, Wu YP and Tang
CH: Amphiregulin enhances cell migration and resistance to
doxorubicin in chondrosarcoma cells through the MAPK pathway. Mol
Carcinog. 57:1816–1824. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elangovan IM, Vaz M, Tamatam CR, Potteti
HR, Reddy NM and Reddy SP: FOSL1 promotes kras-induced lung cancer
through amphiregulin and cell survival gene regulation. Am J Respir
Cell Mol Biol. 58:625–635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hsu YL, Huang MS, Cheng DE, Hung JY, Yang
CJ, Chou SH and Kuo PL: Lung tumor-associated dendritic
cell-derived amphiregulin increased cancer progression. J Immunol.
187:1733–1744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan W, Xu W, Li Y, Jiang W, Li Y, Huang
Q, Chen B, Wu S, Wang Y, Song W, et al: TAZ sensitizes EGFR
wild-type non-small-cell lung cancer to gefitinib by promoting
amphiregulin transcription. Cell Death Dis. 10:2832019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Taniguchi H, Takeuchi S, Fukuda K,
Nakagawa T, Arai S, Nanjo S, Yamada T, Yamaguchi H, Mukae H and
Yano S: Amphiregulin triggered epidermal growth factor receptor
activation confers in vivo crizotinib-resistance of EML4-ALK lung
cancer and circumvention by epidermal growth factor receptor
inhibitors. Cancer Sci. 108:53–60. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitry MA, Laurent D, Keith BL, Sira E,
Eisenberg CA, Eisenberg LM, Joshi S, Gupte S and Edwards JG:
Accelerated cardiomyocyte senescence contributes to late-onset
doxorubicin-induced cardiotoxicity. Am J Physiol Cell Physiol.
318:C380–C391. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma A and Almasan A: Autophagy and PTEN
in DNA damage-induced senescence. Adv Cancer Res. 150:249–284.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L,
Qian M, Guo J, Xu J, Cao L, et al: Targeting amphiregulin (AREG)
derived from senescent stromal cells diminishes cancer resistance
and averts programmed cell death 1 ligand (PD-L1)-mediated
immunosuppression. Aging Cell. 18:e130272019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kannan MB, Solovieva V and Blank V: The
small MAF transcription factors MAFF, MAFG and MAFK: Current
knowledge and perspectives. Biochim Biophys Acta. 1823:1841–1846.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okita Y, Kimura M, Xie R, Chen C, Shen LT,
Kojima Y, Suzuki H, Muratani M, Saitoh M, Semba K, et al: The
transcription factor MAFK induces EMT and malignant progression of
triple-negative breast cancer cells through its target GPNMB. Sci
Signal. 10:eaak93972017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ikeda H, Nishi S and Sakai M:
Transcription factor Nrf2/MafK regulates rat placental glutathione
S-transferase gene during hepatocarcinogenesis. Biochem J.
380:515–521. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nicolas A, Deplanche M, Commere PH, Diot
A, Genthon C, Marques da Silva W, Azevedo V, Germon P, Jamme H,
Guédon E, et al: Transcriptome architecture of osteoblastic cells
infected with Staphylococcus aureus reveals strong inflammatory
responses and signatures of metabolic and epigenetic dysregulation.
Front Cell Infect Microbiol. 12:8542422022. View Article : Google Scholar : PubMed/NCBI
|
